US Stock MarketDetailed Quotes

GNCAQ GENOCEA BIOSCIENCES INC

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose May 31 16:00 ET
58.78Market Cap0.00P/E (TTM)

GENOCEA BIOSCIENCES INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.72%-15.21M
-8.93%-45.37M
-15.17%-11.11M
-36.92%-11.36M
-6.01%-10.51M
10.17%-12.39M
-10.38%-41.65M
-7.30%-9.64M
23.22%-8.3M
-29.74%-9.92M
Net income from continuing operations
-33.34%-15.98M
24.06%-33.2M
11.38%-13.28M
20.48%-3.62M
61.92%-4.31M
6.77%-11.98M
-12.23%-43.71M
-60.16%-14.99M
39.52%-4.56M
-74.30%-11.32M
Operating gains losses
98.71%-11K
-126.57%-20.14M
-113.43%-387K
22.15%-8.38M
-4,637.39%-10.52M
-9.35%-854K
-801.52%-8.89M
524.93%2.88M
-388.08%-10.77M
94.29%-222K
Depreciation and amortization
4.99%400K
36.82%1.56M
50.55%408K
27.65%397K
32.50%371K
38.04%381K
3.74%1.14M
-0.37%271K
13.09%311K
0.72%280K
Other non cash items
-56.42%95K
-87.30%609K
-9.72%130K
-96.93%133K
0.79%128K
12.95%218K
719.83%4.8M
26.32%144K
907.44%4.33M
204.96%127K
Change In working capital
16.19%-616K
-28.88%2.17M
-31.37%1.01M
-149.54%-916K
281.88%2.8M
27.59%-735K
331.13%3.04M
580.18%1.48M
181.71%1.85M
-65.23%734K
-Change in prepaid assets
----
-11.99%-1.18M
----
----
----
----
-30.88%-1.05M
----
----
----
-Change in payables and accrued expense
----
92.59%2.99M
----
----
----
----
622.22%1.55M
----
----
----
-Change in other current assets
----
-67.22%296K
----
----
----
----
516.13%903K
----
----
----
-Change in other working capital
----
-96.40%59K
----
----
----
----
--1.64M
----
----
----
Cash from discontinued investing activities
Operating cash flow
-22.72%-15.21M
-8.93%-45.37M
-15.17%-11.11M
-36.92%-11.36M
-6.01%-10.51M
10.17%-12.39M
-10.38%-41.65M
-7.30%-9.64M
23.22%-8.3M
-29.74%-9.92M
Investing cash flow
Cash flow from continuing investing activities
10.06%-939K
-25.56%-3.21M
32.70%-920K
19.70%-530K
-129.58%-714K
-381.11%-1.04M
-135.05%-2.56M
-1,068.38%-1.37M
-97.01%-660K
24.88%-311K
Net PPE purchase and sale
10.06%-939K
-25.56%-3.21M
32.70%-920K
19.70%-530K
-129.58%-714K
-381.11%-1.04M
-135.05%-2.56M
-1,068.38%-1.37M
-97.01%-660K
24.88%-311K
Cash from discontinued investing activities
Investing cash flow
10.06%-939K
-25.56%-3.21M
32.70%-920K
19.70%-530K
-129.58%-714K
-381.11%-1.04M
-135.05%-2.56M
-1,068.38%-1.37M
-97.01%-660K
24.88%-311K
Financing cash flow
Cash flow from continuing financing activities
-190.57%-863K
-92.90%5.96M
-91.60%265K
-99.46%399K
-4.05%5.59M
-175.19%-297K
58.50%83.85M
22.21%3.15M
13,281.24%74.47M
-84.54%5.83M
Net issuance payments of debt
68.62%-1.25M
-3,805.22%-5.23M
-5,334.78%-1.25M
--0
--0
-8,751.11%-3.98M
93.02%-134K
---23K
93.91%-33K
93.84%-33K
Net common stock issuance
-90.27%387K
-86.47%11.35M
-52.97%1.46M
-99.47%397K
-4.90%5.52M
804.32%3.98M
53.35%83.84M
23.94%3.1M
324,017.39%74.5M
-84.81%5.8M
Proceeds from stock option exercised by employees
--0
50.68%220K
-26.25%59K
-66.67%2K
25.00%75K
--84K
-3.31%146K
-2.44%80K
--6K
5.26%60K
Net other financing activities
----
---377K
--0
--0
--0
---377K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-190.57%-863K
-92.90%5.96M
-91.60%265K
-99.46%399K
-4.05%5.59M
-175.19%-297K
58.50%83.85M
22.21%3.15M
13,281.24%74.47M
-84.54%5.83M
Net cash flow
Beginning cash position
-53.01%37.78M
97.26%80.4M
-43.87%49.54M
168.39%61.03M
145.64%66.67M
97.26%80.4M
52.78%40.76M
86.67%88.26M
-61.45%22.74M
-7.54%27.14M
Current changes in cash
-23.86%-17.01M
-207.51%-42.62M
-49.69%-11.76M
-117.54%-11.49M
-28.06%-5.64M
-0.85%-13.73M
181.55%39.64M
-20.44%-7.86M
659.69%65.52M
-114.85%-4.4M
End cash Position
-68.85%20.77M
-53.01%37.78M
-53.01%37.78M
-43.87%49.54M
168.39%61.03M
145.64%66.67M
97.26%80.4M
97.26%80.4M
86.67%88.26M
-61.45%22.74M
Free cash flow
-19.76%-16.17M
-10.00%-48.66M
-9.33%-12.04M
-32.69%-11.89M
-9.70%-11.23M
3.76%-13.5M
-13.81%-44.24M
-20.60%-11.01M
19.57%-8.96M
-26.71%-10.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.72%-15.21M-8.93%-45.37M-15.17%-11.11M-36.92%-11.36M-6.01%-10.51M10.17%-12.39M-10.38%-41.65M-7.30%-9.64M23.22%-8.3M-29.74%-9.92M
Net income from continuing operations -33.34%-15.98M24.06%-33.2M11.38%-13.28M20.48%-3.62M61.92%-4.31M6.77%-11.98M-12.23%-43.71M-60.16%-14.99M39.52%-4.56M-74.30%-11.32M
Operating gains losses 98.71%-11K-126.57%-20.14M-113.43%-387K22.15%-8.38M-4,637.39%-10.52M-9.35%-854K-801.52%-8.89M524.93%2.88M-388.08%-10.77M94.29%-222K
Depreciation and amortization 4.99%400K36.82%1.56M50.55%408K27.65%397K32.50%371K38.04%381K3.74%1.14M-0.37%271K13.09%311K0.72%280K
Other non cash items -56.42%95K-87.30%609K-9.72%130K-96.93%133K0.79%128K12.95%218K719.83%4.8M26.32%144K907.44%4.33M204.96%127K
Change In working capital 16.19%-616K-28.88%2.17M-31.37%1.01M-149.54%-916K281.88%2.8M27.59%-735K331.13%3.04M580.18%1.48M181.71%1.85M-65.23%734K
-Change in prepaid assets -----11.99%-1.18M-----------------30.88%-1.05M------------
-Change in payables and accrued expense ----92.59%2.99M----------------622.22%1.55M------------
-Change in other current assets -----67.22%296K----------------516.13%903K------------
-Change in other working capital -----96.40%59K------------------1.64M------------
Cash from discontinued investing activities
Operating cash flow -22.72%-15.21M-8.93%-45.37M-15.17%-11.11M-36.92%-11.36M-6.01%-10.51M10.17%-12.39M-10.38%-41.65M-7.30%-9.64M23.22%-8.3M-29.74%-9.92M
Investing cash flow
Cash flow from continuing investing activities 10.06%-939K-25.56%-3.21M32.70%-920K19.70%-530K-129.58%-714K-381.11%-1.04M-135.05%-2.56M-1,068.38%-1.37M-97.01%-660K24.88%-311K
Net PPE purchase and sale 10.06%-939K-25.56%-3.21M32.70%-920K19.70%-530K-129.58%-714K-381.11%-1.04M-135.05%-2.56M-1,068.38%-1.37M-97.01%-660K24.88%-311K
Cash from discontinued investing activities
Investing cash flow 10.06%-939K-25.56%-3.21M32.70%-920K19.70%-530K-129.58%-714K-381.11%-1.04M-135.05%-2.56M-1,068.38%-1.37M-97.01%-660K24.88%-311K
Financing cash flow
Cash flow from continuing financing activities -190.57%-863K-92.90%5.96M-91.60%265K-99.46%399K-4.05%5.59M-175.19%-297K58.50%83.85M22.21%3.15M13,281.24%74.47M-84.54%5.83M
Net issuance payments of debt 68.62%-1.25M-3,805.22%-5.23M-5,334.78%-1.25M--0--0-8,751.11%-3.98M93.02%-134K---23K93.91%-33K93.84%-33K
Net common stock issuance -90.27%387K-86.47%11.35M-52.97%1.46M-99.47%397K-4.90%5.52M804.32%3.98M53.35%83.84M23.94%3.1M324,017.39%74.5M-84.81%5.8M
Proceeds from stock option exercised by employees --050.68%220K-26.25%59K-66.67%2K25.00%75K--84K-3.31%146K-2.44%80K--6K5.26%60K
Net other financing activities -------377K--0--0--0---377K----------------
Cash from discontinued financing activities
Financing cash flow -190.57%-863K-92.90%5.96M-91.60%265K-99.46%399K-4.05%5.59M-175.19%-297K58.50%83.85M22.21%3.15M13,281.24%74.47M-84.54%5.83M
Net cash flow
Beginning cash position -53.01%37.78M97.26%80.4M-43.87%49.54M168.39%61.03M145.64%66.67M97.26%80.4M52.78%40.76M86.67%88.26M-61.45%22.74M-7.54%27.14M
Current changes in cash -23.86%-17.01M-207.51%-42.62M-49.69%-11.76M-117.54%-11.49M-28.06%-5.64M-0.85%-13.73M181.55%39.64M-20.44%-7.86M659.69%65.52M-114.85%-4.4M
End cash Position -68.85%20.77M-53.01%37.78M-53.01%37.78M-43.87%49.54M168.39%61.03M145.64%66.67M97.26%80.4M97.26%80.4M86.67%88.26M-61.45%22.74M
Free cash flow -19.76%-16.17M-10.00%-48.66M-9.33%-12.04M-32.69%-11.89M-9.70%-11.23M3.76%-13.5M-13.81%-44.24M-20.60%-11.01M19.57%-8.96M-26.71%-10.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg